Sands Capital Ventures — 2022 Investments
5 investments dated 2022 · listed companies and verified rows first · show all
Klaviyo is an AI-powered CRM platform for B2C brands that integrates customer data, marketing automation, customer service, and analytics in a unified solution.
AI & Machine LearningDirect to ConsumerMarketing TechSaaSBoston, US
Andrew Bialecki(Founder)inEd Hallen(Founder)inBenjamin Cook(Executive Officer)inLandon Edmond(Executive Officer)inChano Fernandez(Co-CEO)in
BoardMichael Medici(Director)in
Co-investors515 VenturesAccelAvenir Growth CapitalCross Creek AdvisorsGlynn Capital ManagementHarmony Partners+10 more
Inspirna is a clinical-stage biopharmaceutical company developing novel cancer drugs that target previously undruggable drivers of metastasis using its proprietary miRNA-DRIVEr platform.
BiotechHealthtechMedical DevicesNew York, US
Sohail Tavazoie(Co-Founder & Chair of Scientific Advisory Board)Masoud Tavazoie(Co-Founder & Advisor)in
Co-investorsSofinnova PartnersVivo CapitalStart CapitalNovo Holdings
Red Sift is a cybersecurity company whose founders previously built email security and mobile products.
CybersecurityEnterprise SoftwareSaaS
Rahul Powar(Founder)inRandal Pinto(Founder)
Co-investorsHighland EuropeEntrée CapitalIn-Q-TelMMC VenturesSalica Investments
Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease.
AI & Machine LearningDigital HealthHealthtechMedical DevicesDenver, US
James Min, MD(Founder)inJames K. Min(Founder)
BoardLee Cooper(Director)Peter Justin Klein(Director)Scott Barclay(Director)inLouis Samson(Director)
Co-investorsBattery VenturesBreyer CapitalCatalytic Impact FoundationDigiTx Partners LLCEsplanade VenturesInsight Partners+6 more
London-based AI dubbing company whose synthetic-speech technology translated video into other languages; IP acquired by RWS in 2025.
Jesse Shemen(Founder)in
Co-investorsGMG VenturesMercuri.vcOctopus VenturesBDMIEntrepreneur FirstLocalGlobe
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

































